scPharmaceuticals

We have a growing burden of heart failure in the U.S.?As Heart Month Ends, it is important to highlight Heart Failure (HF) as a rising public health challenge, with prevalence and lifetime risk estimates increasing across all demographics.?? ? Key insights: ?? Growing Prevalence: 6.7 million Americans have HF today. This number is projected to reach 8.7M by 2030, 10.3M by 2040, and 11.4M by 2050. ? ?? Lifetime Risk: The risk of developing HF has risen to approximately?1 in 4?(24%). ?? Age-Related Growth: HF prevalence among those 65-70 years old is expected to reach?8.5%. ?? HFpEF Trends: HF with preserved ejection fraction (HFpEF) is rising, with women facing a higher lifetime risk. ?? At-Risk Populations:? - Stage A (at-risk):?33% of U.S. adults? - Stage B (pre-HF):?24-34%? - Obesity and hypertension remain strong risk factors. ?? Health Disparities:? - HF prevalence is highest among Black individuals and has increased among Black and Hispanic/Latino populations.? - Young and middle-aged Black adults have higher HF prevalence than their White counterparts. ?? Aging Population: HF is most common in adults over?60 years old.? ? As the burden of HF continues to grow, prevention, early intervention, and targeted strategies will be essential. #HeartFailure #Cardiology #PublicHealth

Redefining Cardiorenal Care—Together. At scPharmaceuticals, our mission is clear: to transform cardiorenal care with innovative, integrated treatments that meet the real needs of patients. Every day, our team works to develop accessible healthcare solutions that improve health outcomes and enhance quality of life. This shared purpose drives us forward. As we tackle some of healthcare’s toughest challenges, we do so together—with dedication, collaboration, and a commitment to making a difference. We are proud of the scPharma team that is shaping the future of patient care. #CardiorenalCare #Innovation #Teamwork

American Heart Month may be ending, but the journey to better heart health is ongoing. Keep learning and stay heart-smart. #CardiovascularHealth #Prevention

Heart failure remains a major health challenge, impacting millions across the U.S. Effective congestion management is essential to optimizing outcomes. Evolving treatment approaches are transforming the landscape of heart failure care. Stay informed on the latest developments. #HeartFailure #HeartHealth #Cardiology

The Technology and Heart Failure Therapeutics conference brought together leading minds to explore the latest advancements in?cardiovascular and renal therapies. Representing?scPharmaceuticals, Daniel Maher?and?Malinda Anders, MBA?engaged in discussions on the evolving landscape of heart failure treatment, outpatient care, and how innovation is reshaping patient management. ? Their participation underscores?our commitment to improving access and outcomes for patients?by staying at the forefront of?scientific and clinical developments. ? A big thank you to the organizers, Cardiovascular Research Foundation, for a great event! Looking forward to continued conversations with our peers in the field. ? #CardiovascularCare #HeartFailure #Innovation #THT

scPharmaceuticals?is at #THT2025 today. Please visit us at booth 12 to learn more about treatment options for your heart failure patients with congestion.? #heartfailure #cardiology #scPharmaceuticals #scPharma $SCPH

Will you be at #THT2025 today??scPharmaceuticals?is in-person at booth 12. Visit us to learn more about outpatient care for patients with congestion due to fluid overload.? #heartfailure #cardiology #scPharmaceuticals #scPharma $SCPH

Will you be at #THT2025 today??scPharmaceuticals?is in-person at booth 12. Visit us to learn more about outpatient care for patients with congestion due to fluid overload.? #heartfailure #cardiology #scPharmaceuticals #scPharma $SCPH

scPharmaceuticals?is attending #THT2025. Join us in Boston, MA from February 11-12th at booth 12 as we connect with leading healthcare professionals in heart failure.? #heartfailure #cardiology #scPharmaceuticals #scPharma $SCPH?

Visit us at booth 12 to learn more about treatment options for heart failure patients. #heartfailure #cardiology #scPharmaceuticals #scPharma